DCGI suspends nod to Entod's new eye drops over unapproved 'claims'

India's drug regulator has suspended Entod Pharmaceuticals' permission to manufacture and sell PresVu Eye Drops. The company did not obtain clearance for its claim that the drops reduce dependency on reading glasses for presbyopia. Entod plans to challenge the suspension in court, asserting that their clinical trials demonstrated efficacy and safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dh4IsHS
via IFTTT